Analog Devices heads into the week with an unusual divergence: the stock is down 4.4% over five sessions while short sellers are actively covering, not adding.
The short side is backing away from ADI at a meaningful clip. Short interest dropped 14% over the past week to 1.9% of the free float — a level too low to cause real squeeze mechanics, but the direction of travel is notable. That 14% weekly unwind came almost entirely in a single session on June 9, when shorts shed roughly 10% of their position in one day. The borrow market reflects no stress: availability is effectively unlimited with hundreds of millions of shares available to lend, and cost to borrow, while up 21% on the week to 0.51%, remains near record-low absolute levels. The ORTEX short score has been drifting lower all week to 31.1 — in the lower third of the universe — confirming there is no meaningful bear thesis being actively pressed in the lending market. Options tell a similar story: the put/call ratio sits at 0.84, essentially in line with its 20-day average of 0.83, and well below the 52-week high of 1.00. Defensive hedging is not notably elevated.
The Street is decisively constructive, and has grown more so since the May 20 earnings print. Ten firms raised price targets in the two days following results — JP Morgan's Harlan Sur moving to $450 from $400 on May 26 being the most recent bellwether action, while Wells Fargo set the high end of the range at $515. The consensus mean target of $451 implies roughly 11% upside from current levels near $404. Bulls point to 's exposure to AI infrastructure and EV adoption as long-cycle growth drivers, and the company's quality metrics — strong Piotroski F-score, FCF margins near 30% — underpin the constructive view. Bears flag the PE at 30x and EV/EBITDA around 21x as demanding given the 30-day multiple compression (PE has contracted nearly 5 turns in a month), and worry that high inventory levels and intensifying competition in analog from AI-adjacent entrants could cap near-term upside. Factor scores reinforce the quality angle: dividend rank is in the 97th percentile, and EPS momentum over 30 days sits at the 79th percentile, though the 90-day reading has slipped back to the 50th.
Insider activity is worth flagging as a counterweight to that bullish analyst chorus. CEO Vincent Roche has sold ADI shares in at least five separate transactions since May 1, totalling over $28 million in aggregate across those disclosed trades. SVP Martin Cotter added another $7.4 million sale on June 2. Net insider activity over the 90-day window reflects approximately $67 million in net selling — a volume that stands out even accounting for routine executive liquidity programs. None of the individual trades carry high significance scores, and they do not in isolation signal distress, but the persistence and scale of the CEO's selling at prices in the $395–$420 range deserves attention given the stock's proximity to those levels now.
Among close peers, ADI's 4.4% weekly decline looks moderate. ON Semiconductor fell 9% on the week. AEHR Test Systems shed 16.5%. TXN, MPWR, and MCHP all dropped 5-6%. The analog semiconductor space clearly faced sector-wide selling pressure, and ADI held up relatively well — which, combined with the short covering, suggests the week's move was more about macro or sector rotation than any ADI-specific deterioration.
The next scheduled earnings event is August 19. Between now and then, the relevant watch points are whether CEO selling activity continues at recent pace as the stock recovers toward the $415–$420 range where much of it occurred, and whether the post-earnings analyst target upgrades — clustered between $450 and $515 — begin to attract fresh institutional positioning or whether multiple compression continues to narrow the gap from the other direction.
See the live data behind this article on ORTEX.
Open ADI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
